Recce Pharmaceuticals Ltd

Recce Pharmaceuticals Ltdverified

RECEF

Price:

$0.22

Market Cap:

$177.85M

Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic anti–infectives in Australia, the United States, and the United Kingdom. The company's lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. It also develops RECCE 529, a synthetic anti-infective for viral infections; and RECCE 435, a synthetic polymer anti-infective. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.

Industry

Biotechnology

IPO Date

2022-08-12

Stock Exchange

OTC

Ticker

RECEF

The Current Ratio as of December 2025 (TTM) for Recce Pharmaceuticals Ltd (RECEF) is 1.86

According to Recce Pharmaceuticals Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 1.86. This represents a change of 106.47% compared to the average of 0.90 of the last 4 quarters.

Recce Pharmaceuticals Ltd (RECEF) Historical Current Ratio (quarterly & annually)

How has RECEF Current Ratio performed in the past?

The mean historical Current Ratio of Recce Pharmaceuticals Ltd over the last ten years is 5.27. The current 1.86 Current Ratio has changed 3.43% with respect to the historical average. Over the past ten years (40 quarters), RECEF's Current Ratio was at its highest in in the June 2021 quarter at 19.64. The Current Ratio was at its lowest in in the December 2012 quarter at 0.

Quarterly (TTM)
Annual

Average

5.27

Median

1.78

Minimum

0.34

Maximum

19.64

Recce Pharmaceuticals Ltd (RECEF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Recce Pharmaceuticals Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 769.66%

Maximum Annual Current Ratio = 19.64

Minimum Annual Increase = -91.94%

Minimum Annual Current Ratio = 0.34

Quarterly (TTM)
Annual
YearCurrent RatioChange
20251.86445.02%
20240.34-15.12%
20230.40-91.94%
20224.98-74.65%
202119.64534.79%
20203.09769.66%
20190.36-79.09%
20181.701.78%
20171.67-91.04%
201618.650.99%

Recce Pharmaceuticals Ltd (RECEF) Average Current Ratio

How has RECEF Current Ratio performed in the past?

The current Current Ratio of Recce Pharmaceuticals Ltd (RECEF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0.87

5-year avg

5.44

10-year avg

5.27

Recce Pharmaceuticals Ltd (RECEF) Current Ratio vs. Peers

How is RECEF’s Current Ratio compared to its peers?

Recce Pharmaceuticals Ltd’s Current Ratio is greater than Adocia S.A. (1.08), less than Faron Pharmaceuticals Oy (1.89), less than AnGes, Inc. (2.09), less than Broncus Holding Corporation (26.99), less than EKF Diagnostics Holdings plc (4.62), less than Eupraxia Pharmaceuticals Inc. (8.72), less than ACS Global, Inc. (0), less than Prescient Therapeutics Limited (0), greater than Adocia S.A. (1.08), greater than Planet 13 Holdings Inc. (1.81),

Build a custom stock screener for Recce Pharmaceuticals Ltd (RECEF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Recce Pharmaceuticals Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Recce Pharmaceuticals Ltd (RECEF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Recce Pharmaceuticals Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Recce Pharmaceuticals Ltd's Current Ratio?

How is the Current Ratio calculated for Recce Pharmaceuticals Ltd (RECEF)?

What is the highest Current Ratio for Recce Pharmaceuticals Ltd (RECEF)?

What is the 3-year average Current Ratio for Recce Pharmaceuticals Ltd (RECEF)?

What is the 5-year average Current Ratio for Recce Pharmaceuticals Ltd (RECEF)?

How does the current Current Ratio for Recce Pharmaceuticals Ltd (RECEF) compare to its historical average?